Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 9, 2022
Behavioral Activation in Nursing Homes to Treat Depression (BAN-Dep): Results From a Clustered, Randomized, Single-Blinded, Controlled Clinical TrialOsvaldo P Almeida, Hema Patel, Diana Velasquez, et al.Lancet (London, England)|July 28, 2016
Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trialDavid A Richards, David Ekers, Dean McMillan, et al.Trials|November 21, 2014
CASPER plus (CollAborative care in Screen-Positive EldeRs with major depressive disorder): study protocol for a randomised controlled trialKaren Overend, Helen Lewis, Della Bailey, et al.Pilot and Feasibility Studies|June 5, 2019
Community Pharmacies Mood Intervention Study (CHEMIST): feasibility and external pilot randomised controlled trial protocolElizabeth Littlewood, Shehzad Ali, Jay Badenhorst, et al.Pilot and Feasibility Studies|February 4, 2022
The feasibility and acceptability of a brief psychological intervention for adults with long-term health conditions and subthreshold depression delivered via community pharmacies: a mixed methods evaluation-the Community Pharmacies Mood Intervention Study (CHEMIST)Carolyn A Chew-Graham, Charlotte E W Kitchen, Samantha Gascoyne, et al.Journal of Affective Disorders|December 8, 2024
A randomised controlled feasibility trial of Behavioural activation as a treatment for people with diabetes and depression: (DiaDeM feasibility trial)Naveed Ahmed, Gerardo A Zavala, Faraz Siddiqui, et al.Health Technology Assessment (Winchester, England)|September 1, 2017
Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depressionDavid A Richards, Shelley Rhodes, David Ekers, et al.Plos Medicine|October 12, 2021
Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trialSimon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.Plos One|March 24, 2022
Behavioural Activation for Social IsoLation (BASIL+) trial (Behavioural activation to mitigate depression and loneliness among older people with long-term conditions): Protocol for a fully-powered pragmatic randomised controlled trialLauren Burke, Elizabeth Littlewood, Samantha Gascoyne, et al.The Lancet. Healthy Longevity|February 4, 2024
Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trialSimon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.Pageof 6